Zobrazeno 1 - 9
of 9
pro vyhledávání: '"N. N. Petenko"'
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 94-100 (2020)
Merkel cell carcinoma is a rare and aggressive skin tumor that is difficult to treat even at early stages. Treatment approaches for advanced disease are limited and standard chemotherapy provides short-lived disease control in half of patients withou
Externí odkaz:
https://doaj.org/article/ea08a89b8d664dcc8c98ef38178ecf93
Autor:
A. G. Kotelnikov, D. V. Podluzhnyy, I. S. Proskuryakov, I. E. Sinelnikov, N. N. Petenko, E. R. Virshke
Publikováno v:
Тазовая хирургия и онкология, Vol 9, Iss 4, Pp 43-47 (2019)
This article presents the experience of surgical management of pancreatic and colon metastases from kidney cancer, detected 10 years after nephrectomy. Atypical resection of the pancreas combined with right-sided hemicolectomy was performed. The post
Externí odkaz:
https://doaj.org/article/9e50a48126334fa6a98cc4f5f446083f
Autor:
N. N. Petenko, L. V. Demidov
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 42-48 (2018)
Most patients with basal cell cancer (BCC) can be cured if timely diagnosed. However approximately 1,3% of BCCs may develop into locally-advanced and sometimes even metastatic disease when local treatment options are limited and systemic therapy is w
Externí odkaz:
https://doaj.org/article/388b88621111490aa7914848cdc984ba
Autor:
D. R. Naskhletashvili, V. A. Gorbunova, A. Kh. Bekyashev, L. V. Demidov, G. Yu. Kharkevich, S. M. Banov, I. V. Samoylenko, K. А. Baryshnikov, K. V. Orlova, I. А. Utyashev, N. N. Petenko, I. G. Markina, E. A. Moskvina, S. V. Medvedev
Publikováno v:
Опухоли головы и шеи, Vol 6, Iss 4, Pp 30-34 (2017)
The effectiveness of traditional chemotherapy (with temozolomide, fotemustine, lomustine) alone or in combination with whole brain radiotherapy in melanoma patients with cerebral metastases does not exceed 7–10 % with no significant impact on survi
Externí odkaz:
https://doaj.org/article/b2ac3cf2f6194ffca9ad2854e4269286
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 94-100 (2020)
Merkel cell carcinoma is a rare and aggressive skin tumor that is difficult to treat even at early stages. Treatment approaches for advanced disease are limited and standard chemotherapy provides short-lived disease control in half of patients withou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75de4c39b2329c57c6c6522d78b0db1c
https://doi.org/10.21518/2079-701x-2020-9-94-100
https://doi.org/10.21518/2079-701x-2020-9-94-100
Autor:
L. V. Demidov, N. N. Petenko
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 42-48 (2018)
Most patients with basal cell cancer (BCC) can be cured if timely diagnosed. However approximately 1,3% of BCCs may develop into locally-advanced and sometimes even metastatic disease when local treatment options are limited and systemic therapy is w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ab8da93115b536c0ba8c7e3d534197
https://www.med-sovet.pro/jour/article/view/2531
https://www.med-sovet.pro/jour/article/view/2531
Autor:
D. R. Naskhletashvili, V. A. Gorbunova, A. Kh. Bekyashev, L. V. Demidov, G. Yu. Kharkevich, S. M. Banov, I. V. Samoylenko, K. А. Baryshnikov, K. V. Orlova, I. А. Utyashev, N. N. Petenko, I. G. Markina, E. A. Moskvina, S. V. Medvedev
Publikováno v:
Opuholi Golovy i Šei, Vol 6, Iss 4, Pp 30-34 (2017)
The effectiveness of traditional chemotherapy (with temozolomide, fotemustine, lomustine) alone or in combination with whole brain radiotherapy in melanoma patients with cerebral metastases does not exceed 7–10 % with no significant impact on survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f2c99091183cc3900f076001482d908
https://doi.org/10.17650/2222-1468-2016-6-4-30-34
https://doi.org/10.17650/2222-1468-2016-6-4-30-34
Publikováno v:
Voprosy onkologii. 57(1)
We evaluated overall and relapse-free survival in patients with metastatic renal cell carcinoma (MRCC) with poor prognosis. The study involved 92 patients (median age 54.1 years, male 63%, female 29%), retrospectively; 48.9% had poor prognosis. They
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a608ccf900b12960e585e0a053cb767
https://pubmed.ncbi.nlm.nih.gov/21598708
https://pubmed.ncbi.nlm.nih.gov/21598708
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (10)
Methods of cancer immunotherapy with dendritic cell-based vaccines, activated outside the organism, as well as techniques employing genetically modified whole-cell antitumoral vaccines, transfected by cytokine gens and stimulating the patient's dendr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0dde797d2558196ca1005165483ed6a0
https://pubmed.ncbi.nlm.nih.gov/18050681
https://pubmed.ncbi.nlm.nih.gov/18050681